VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
SystImmune to Present New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline at ASCO 2026
SystImmune to Present New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline at ASCO 2026
May 22, 2026 05:00 CST Updated 05:23
Share:
